SCHEMBL7651975

SCHEMBL7651975

CN(Cc1cncc(CN(C)C(CO)C(O)CO)c1)C(CO)C(O)CO

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNP P00491 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7106669 0.80 PNP (0.41) PNP
SCHEMBL7656354 0.79 PNP (0.36) PNP
SCHEMBL7661155 0.77 CHRNB2 (0.38)
SCHEMBL7109158 0.76 PNP (0.46) PNP
SCHEMBL7656330 0.71 ALDH1A1 (0.40)
SCHEMBL7654642 0.70 PNP (0.41) PNP
SCHEMBL7659642 0.69 PNP (0.39) PNP
SCHEMBL7654547 0.68 KMT2A (0.36) PNP
SCHEMBL7654381 0.67
SCHEMBL7663487 0.67 PNP (0.34) PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed